These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 1346980)

  • 1. Cholesterol lowering as a treatment for established coronary heart disease.
    LaRosa JC; Cleeman JI
    Circulation; 1992 Mar; 85(3):1229-35. PubMed ID: 1346980
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease: expert group recommendations.
    Sacks FM;
    Am J Cardiol; 2002 Jul; 90(2):139-43. PubMed ID: 12106843
    [No Abstract]   [Full Text] [Related]  

  • 3. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG; Paterson JR
    QJM; 2000 Sep; 93(9):567-74. PubMed ID: 10984551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benefits of fibrate drugs in coronary heart disease patients with normal cholesterol levels.
    Havel RJ
    Circulation; 1997 Oct; 96(7):2113-4. PubMed ID: 9337175
    [No Abstract]   [Full Text] [Related]  

  • 5. Trials of lipid-lowering therapy in primary prevention of coronary heart disease.
    Jones PH
    Curr Opin Lipidol; 1995 Dec; 6(6):365-8. PubMed ID: 8750249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-lowering therapy after an atherosclerotic event.
    Roberts WC
    Am J Cardiol; 1989 Sep; 64(10):693-5. PubMed ID: 2782265
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of addition of exercise to therapeutic lifestyle changes diet in enabling women and men with coronary heart disease to reach Adult Treatment Panel III low-density lipoprotein cholesterol goal without lowering high-density lipoprotein cholesterol.
    Welty FK; Stuart E; O'Meara M; Huddleston J
    Am J Cardiol; 2002 May; 89(10):1201-4. PubMed ID: 12008176
    [No Abstract]   [Full Text] [Related]  

  • 8. The Helsinki Heart Study: basic design and randomization procedure.
    Mänttäri M; Elo O; Frick MH; Haapa K; Heinonen OP; Heinsalmi P; Helo P; Huttunen JK; Kaitaniemi P; Koskinen P
    Eur Heart J; 1987 Oct; 8 Suppl I():1-29. PubMed ID: 3322826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cholesterol in 1989].
    Daubresse JC
    Rev Med Liege; 1989 Jun; 44(11):381-7. PubMed ID: 2664966
    [No Abstract]   [Full Text] [Related]  

  • 10. The emerging role of HDL cholesterol. Is it time to focus more energy on raising high-density lipoprotein levels?
    Safeer RS; Cornell MO
    Postgrad Med; 2000 Dec; 108(7):87-90, 93-8. PubMed ID: 11126145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of diabetic dyslipidemia.
    Garg A
    Am J Cardiol; 1998 Feb; 81(4A):47B-51B. PubMed ID: 9526814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niacin after coronary bypass grafting and for coronary disease prevention.
    Parsons WB
    Circulation; 2001 Jul; 104(2):E7. PubMed ID: 11447097
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).
    Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
    JAMA; 2001 May; 285(19):2486-97. PubMed ID: 11368702
    [No Abstract]   [Full Text] [Related]  

  • 15. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy.
    Boden WE; Pearson TA
    Am J Cardiol; 2000 Mar; 85(5):645-50, A10. PubMed ID: 11078282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The place of HDL in cholesterol management. A perspective from the National Cholesterol Educational Program.
    Grundy SM; Goodman DW; Rifkind BM; Cleeman JI
    Arch Intern Med; 1989 Mar; 149(3):505-10. PubMed ID: 2645842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ineffectiveness of a commonly recommended lipid-lowering diet in significantly lowering the serum total and low-density lipoprotein cholesterol levels.
    Roberts WC
    Am J Cardiol; 1994 Mar; 73(8):623-4. PubMed ID: 8147319
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diet in the treatment of atherogenic dyslipoproteinemias].
    Oganov RG; Perova NV
    Kardiologiia; 1990 May; 30(5):5-7. PubMed ID: 2391809
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of raising high-density lipoprotein cholesterol for prevention of coronary heart disease.
    Teramoto T
    Curr Atheroscler Rep; 2002 Sep; 4(5):327-8. PubMed ID: 12162930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.